Samuel Sandy, Chang Enchi K, Gupta Sanchay, Chachanidze Marika, Neeson Cameron E, Miller John B, Chang Ta Chen, Solá-Del Valle David A
Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
Massachusetts Eye and Ear, Boston, MA, USA.
J Ophthalmol. 2022 Jul 20;2022:5947992. doi: 10.1155/2022/5947992. eCollection 2022.
To assess outcomes of anterior chamber (AC), sulcus, and pars plana (PP) glaucoma drainage device (GDD) placement in glaucoma patients. . Retrospective evaluation of glaucoma patients who underwent GDD insertion in the AC, sulcus, or PP at Massachusetts Eye and Ear between November 2016 and May 2021. Patients who received AC, sulcus, and pars plana tubes were selected using simple random sampling, and the first 40 patients meeting inclusion criteria were analyzed. Main outcome measures were cumulative success probabilities from Kaplan-Meier (KM) analyses, intraocular pressure (IOP), medication burden, and complication rates.
The PP group had a larger proportion of Ahmed GDDs and was younger on average with less severe glaucoma compared to patients with AC or sulcus tubes. The PP group had a higher proportion of mixed-mechanism glaucoma and lower proportion of primary open-angle glaucoma. With success defined as IOP reduction ≥20% and 5 < IOP ≤ 21 mm Hg, the Kaplan-Meier cumulative success probabilities for all three GDD locations were not significantly different. No significant differences were found in complication rates between all groups after 3 months. Patients with PP GDD had significantly lower medication burden than those with AC or sulcus GDDs up to 1.5 years postoperatively (1.7 ± 1.1, 3.0 ± 1.4, and 2.8 ± 1.2 for PP, AC, and sulcus, respectively; =0.017).
PP GDDs may be more effective in lowering medication burden than AC or sulcus tubes without compromising long-term safety.
评估青光眼患者前房(AC)、巩膜沟和睫状体平坦部(PP)青光眼引流装置(GDD)植入的效果。回顾性评估2016年11月至2021年5月在马萨诸塞州眼耳医院接受AC、巩膜沟或PP部位GDD植入的青光眼患者。采用简单随机抽样选择接受AC、巩膜沟和睫状体平坦部引流管的患者,并对前40名符合纳入标准的患者进行分析。主要观察指标为Kaplan-Meier(KM)分析的累积成功概率、眼压(IOP)、药物负担和并发症发生率。
与AC或巩膜沟引流管的患者相比,PP组使用艾哈迈德GDD的比例更高,平均年龄更小,青光眼病情较轻。PP组混合机制性青光眼的比例更高,原发性开角型青光眼的比例更低。将成功定义为眼压降低≥20%且5<眼压≤21 mmHg时,所有三个GDD植入部位的Kaplan-Meier累积成功概率无显著差异。3个月后所有组之间的并发症发生率无显著差异。术后长达1.5年,PP GDD患者的药物负担明显低于AC或巩膜沟GDD患者(PP、AC和巩膜沟分别为1.7±1.1、3.0±1.4和2.8±1.2;P=0.017)。
PP GDD在降低药物负担方面可能比AC或巩膜沟引流管更有效,且不影响长期安全性。